quantisnow
FeedTopReportsPricing
⌘K
Live feed
21:30:38·496d
INSIDERFiling
Lumos Pharma Inc. logo

Director Mccracken Joseph S returned 15,721 shares to the company, closing all direct ownership in the company (SEC Form 4)

LUMO· Lumos Pharma Inc.
Health Care
Original source

Companies

  • LUMO
    Lumos Pharma Inc.
    Health Care

Recent analyst ratings

  • Nov 4UpdateHC Wainwright & Co.$28.00
  • Jul 21UpdateHC Wainwright & Co.$27.00

Related

  • PR380d
    Aviceda Therapeutics Appoints Ophthalmology Innovator and Industry Leader Dr. Emmett T. Cunningham, Jr. to Board of Directors
  • SEC487d
    SEC Form 15-12G filed by Lumos Pharma Inc.
  • INSIDER496d
    Chief Executive Officer Hawkins Richard J returned 757,562 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER496d
    Director Zoth Lota S. returned 2,187 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER496d
    Chief Scientific Officer Mckew John C. returned 13,153 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER496d
    Director Johnson Chad Allen returned 1,076 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER496d
    Director Van Es-Johansson An returned 1,100 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER496d
    Director Raffin Thomas A. returned 9,406 shares to the company, closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022